Đang chuẩn bị liên kết để tải về tài liệu:
Genetic polymorphisms of SCN9A are associated with oxaliplatin-induced neuropathy

Không đóng trình duyệt đến khi xuất hiện nút TẢI XUỐNG Tải xuống

Oxaliplatin is a chemotherapy agent active against digestive tumors. Peripheral neuropathy is one of the most important dose-limiting toxicity of this drug. It occurs in around 60–80% of the patients, and 15% of them develop severe neuropathy. The pathophysiology of oxaliplatin neurotoxicity remains unclear. |